Functionalization of Platinum Complexes for Biomedical Applications

Accounts of Chemical Research

Volumn 48, Issue 9, 2015, Pages 2622-2631

  Wang, Xiaoyong ^a   Wang, Xiaohui ^b,c   Guo, Zijian ^a,b  

^a NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c NANJING TECH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; COORDINATION COMPOUND; PLATINUM;

CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; TRENDS;

ANTINEOPLASTIC AGENTS; CISPLATIN; COORDINATION COMPLEXES; DRUG DELIVERY SYSTEMS; HUMANS; PLATINUM;

EID: 84941638792     PISSN: 00014842     EISSN: 15204898     Source Type: Journal    
DOI: 10.1021/acs.accounts.5b00203     Document Type: Article

References (68)

1. Kaluderović, G. N.; Paschke, R. Anticancer metallotherapeutics in preclinical development Curr. Med. Chem. 2011, 18, 4738-4752 10.2174/092986711797535308
2. Wheate, N. J.; Walker, S.; Craig, G. E.; Oun, R. The status of platinum anticancer drugs in the clinic and in clinical trials Dalton Trans. 2010, 39, 8113-8127 10.1039/c0dt00292e
3. Wang, X. Y.; Guo, Z. J. New trends and future developments of Pt-based antitumor drugs. In Bioinorganic Medicinal Chemistry; Alessio, E., Ed.; WILEY-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2011; pp 97-149.
4. Burger, H.; Loos, W. J.; Eechoute, K.; Verweij, J.; Mathijssen, R. H. J.; Wiemer, E. A. C. Drug transporters of platinum-based anticancer agents and their clinical significance Drug Resist. Updates 2011, 14, 22-34 10.1016/j.drup.2010.12.002
5. Harper, B. W.; Krause-Heuer, A. M.; Grant, M. P.; Manohar, M.; Garbutcheon-Singh, K. B.; Aldrich-Wright, J. R. Advances in platinum chemotherapeutics Chem.-Eur. J. 2010, 16, 7064-7077 10.1002/chem.201000148
6. Xue, X.; You, S.; Zhang, Q.; Wu, Y.; Zou, G.-Z.; Wang, P. C.; Zhao, Y.-L.; Xu, Y.; Jia, L.; Zhang, X. N.; Liang, X.-J. Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction Mol. Pharmaceutics 2012, 9, 634-644 10.1021/mp200571k
7. Yang, J.; Sun, X. R.; Mao, W. W.; Sui, M. H.; Tang, J. B.; Shen, Y. Q. Conjugate of Pt(IV)-histone deacetylase inhibitor as a prodrug for cancer chemotherapy Mol. Pharmaceutics 2012, 9, 2793-2800 10.1021/mp200597r
8. Kenche, V. B.; Hung, L. W.; Perez, K.; Volitakes, I.; Ciccotosto, G.; Kwok, J.; Critch, N.; Sherratt, N.; Cortes, M.; Lal, V.; Masters, C. L.; Murakami, K.; Cappai, R.; Adlard, P. A.; Barnham, K. J. Development of a platinum complex as an anti-amyloid agent for the therapy of Alzheimer's disease Angew. Chem., Int. Ed. 2013, 52, 3374-3378 10.1002/anie.201209885
9. Wang, X. Y. Fresh platinum complexes with promising antitumor activity Anticancer Agents Med. Chem. 2010, 10, 396-411 10.2174/1871520611009050396
10. Wang, X. Y.; Guo, Z. J. Targeting and delivery of Pt-based anticancer drugs Chem. Soc. Rev. 2013, 42, 202-224 10.1039/C2CS35259A
11. Fang, J.; Nakamura, H.; Maeda, H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect Adv. Drug Delivery Rev. 2011, 63, 136-151 10.1016/j.addr.2010.04.009
12. Adiseshaiah, P. P.; Hall, J. B.; McNeil, S. E. Nanomaterial standards for efficacy and toxicity assessment Wiley Interdiscip. Rev. -Nanomed. Nanobiotechnol. 2010, 2, 99-112 10.1002/wnan.66
13. Xue, Z. Q.; Lin, M. X.; Zhu, J. H.; Zhang, J. F.; Li, Y. Z.; Guo, Z. J. Platinum(II) compounds bearing bone-targeting group: synthesis, crystal structure and antitumor activity Chem. Commun. 2010, 46, 1212-1214 10.1039/b922222g
14. Iafisco, M.; Palazzo, B.; Martra, G.; Margiotta, N.; Piccinonna, S.; Natile, G.; Gandin, V.; Marzano, C.; Roveri, N. Nanocrystalline carbonate-apatites: role of Ca/P ratio on the upload and release of anticancer platinum bisphosphonates Nanoscale 2012, 4, 206-217 10.1039/C1NR11147G
15. Margiotta, N.; Denora, N.; Ostuni, R.; Laquintana, V.; Anderson, A.; Johnson, S. W.; Trapani, G.; Natile, G. Platinum(II) complexes with bioactive carrier ligands having high affinity for the translocator protein J. Med. Chem. 2010, 53, 5144-5154 10.1021/jm100429r
16. Boohaker, R. J.; Lee, M. W.; Vishnubhotla, P.; Perez, J. M.; Khaled, A. R. The use of therapeutic peptides to target and to kill cancer cells Curr. Med. Chem. 2012, 19, 3794-3804 10.2174/092986712801661004
17. Chin, C. F.; Wong, D. Y. Q.; Jothibasu, R.; Ang, W. H. Anticancer platinum(IV) prodrugs with novel modes of activity Curr. Top. Med. Chem. 2011, 11, 2602-2612 10.2174/156802611798040778
18. Yuan, Y.; Kwok, R. T. K.; Tang, B. Z.; Liu, B. Targeted theranostic platinum(IV) prodrug with a built-in aggregation-induced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ J. Am. Chem. Soc. 2014, 136, 2546-2554 10.1021/ja411811w
19. Gandioso, A.; Shaili, E.; Massaguer, A.; Artigas, G.; González-Cantó, A.; Woods, J. A.; Sadler, P. J.; Marchán, V. An integrin-targeted photoactivatable Pt(IV) complex as a selective anticancer pro-drug: synthesis and photoactivation studies Chem. Commun. 2015, 51, 9169-9172 10.1039/C5CC03180J
20. Kesavan, K.; Ratliff, J.; Johnson, E. W.; Dahlberg, W.; Asara, J. M.; Misra, P.; Frangioni, J. V.; Jacoby, D. B. Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects J. Biol. Chem. 2010, 285, 4366-4374 10.1074/jbc.M109.066092
21. Graf, N.; Mokhtari, T. E.; Papayannopoulos, I. A.; Lippard, S. J. Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells J. Inorg. Biochem. 2012, 110, 58-63 10.1016/j.jinorgbio.2012.02.012
22. Gaviglio, L.; Gross, A.; Metzler-Nolte, N.; Ravera, M. Synthesis and in vitro cytotoxicity of cis,cis,trans-diamminedichloridodisuccinatoplatinum(IV)-peptide bioconjugates Metallomics 2012, 4, 260-266 10.1039/c2mt00171c
23. Aryal, S.; Hu, C. -M. J.; Zhang, L. F. Polymer-cisplatin conjugate nanoparticles for acid-responsive drug delivery ACS Nano 2010, 4, 251-258 10.1021/nn9014032
24. Paraskar, A. S.; Soni, S.; Chin, K. T.; Chaudhuri, P.; Muto, K. W.; Berkowitz, J.; Handlogten, M. W.; Alves, N. J.; Bilgicer, B.; Dinulescu, D. M.; Mashelkar, R. A.; Sengupta, S. Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 12435-12440 10.1073/pnas.1007026107
25. Peng, X.-H.; Wang, Y. Q.; Huang, D. H.; Wang, Y. X.; Shin, H. J.; Chen, Z. J.; Spewak, M. B.; Mao, H.; Wang, X.; Wang, Y.; Chen, Z.; Nie, S. M.; Shin, D. M. Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles ACS Nano 2011, 5, 9480-9493 10.1021/nn202410f
26. Verma, A.; Stellacci, F. Effect of surface properties on nanoparticle-cell interactions Small 2010, 6, 12-21 10.1002/smll.200901158
27. Xue, X.; Hall, M. D.; Zhang, Q.; Wang, P. C.; Gottesman, M. M.; Liang, X.-J. Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking ACS Nano 2013, 7, 10452-10464 10.1021/nn405004f
28. Oberoi, H. S.; Nukolova, N. V.; Kabanov, A. V.; Bronich, T. K. Nanocarriers for delivery of platinum anticancer drugs Adv. Drug Delivery Rev. 2013, 65, 1667-1685 10.1016/j.addr.2013.09.014
29. Giljohann, D. A.; Seferos, D. S.; Daniel, W. L.; Massich, M. D.; Patel, P. C.; Mirkin, C. A. Gold nanoparticles for biology and medicine Angew. Chem., Int. Ed. 2010, 49, 3280-3294 10.1002/anie.200904359
30. Craig, G. E.; Brown, S. D.; Lamprou, D. A.; Graham, D.; Wheate, N. J. Cisplatin-tethered gold nanoparticles that exhibit enhanced reproducibility, drug loading, and stability: a step closer to pharmaceutical approval? Inorg. Chem. 2012, 51, 3490-3497 10.1021/ic202197g
31. Brown, S. D.; Nativo, P.; Smith, J.-A.; Stirling, D.; Edwards, P. R.; Venugopal, B.; Flint, D. J.; Plumb, J. A.; Graham, D.; Wheate, N. J. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin J. Am. Chem. Soc. 2010, 132, 4678-4684 10.1021/ja908117a
32. Bhattacharyya, S.; Gonzalez, M.; Robertson, J. D.; Bhattacharya, R.; Mukherjee, P. A simple synthesis of a targeted drug delivery system with enhanced cytotoxicity Chem. Commun. 2011, 47, 8530-8532 10.1039/c1cc12902c
33. Patra, C. R.; Bhattacharya, R.; Mukherjee, P. Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer J. Mater. Chem. 2010, 20, 547-554 10.1039/B913224D
34. Min, Y. Z.; Mao, C. Q.; Xu, D. C.; Wang, J.; Liu, Y. Z. Gold nanorods for platinum based prodrug delivery Chem. Commun. 2010, 46, 8424-8426 10.1039/c0cc03108a
35. Min, Y. Z.; Mao, C.-Q.; Chen, S. M.; Ma, G. L.; Wang, J.; Liu, Y. Z. Combating the drug resistance of cisplatin using a platinum prodrug based delivery system Angew. Chem., Int. Ed. 2012, 51, 6742-6747 10.1002/anie.201201562
36. Liu, L.; Ye, Q.; Lu, M.; Lo, Y.-C.; Hsu, Y.-H.; Wei, M.-C.; Chen, Y.-H.; Lo, S.-C.; Wang, S.-J.; Bain, D. J.; Ho, C. A new approach to reduce toxicities and to improve bioavailabilities of platinum-containing anti-cancer nanodrugs Sci. Rep. 2015, 5, 10881 10.1038/srep10881
37. Albanese, A.; Tang, P. S.; Chan, W. C. W. The effect of nanoparticle size, shape, and surface chemistry on biological systems Annu. Rev. Biomed. Eng. 2012, 14, 1-16 10.1146/annurev-bioeng-071811-150124
38. Hao, R.; Xing, R. J.; Xu, Z. C.; Hou, Y. L.; Gao, S.; Sun, S. H. Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles Adv. Mater. 2010, 22, 2729-2742 10.1002/adma.201000260
39. Cho, H.-S.; Dong, Z.; Pauletti, G. M.; Zhang, J.; Xu, H.; Gu, H.; Wang, L.; Ewing, R. C.; Huth, C.; Wang, F.; Shi, D. Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: A multifunctional nanocarrier system for cancer diagnosis and treatment ACS Nano 2010, 4, 5398-5404 10.1021/nn101000e
40. Xing, R. M.; Wang, X. Y.; Zhang, C. L.; Wang, J. Z.; Zhang, Y. M.; Song, Y.; Guo, Z. J. Superparamagnetic magnetite nanocrystal clusters as potential magnetic carriers for the delivery of platinum anticancer drugs J. Mater. Chem. 2011, 21, 11142-11149 10.1039/c1jm11369k
41. Wang, J. Z.; Wang, X. Y.; Song, Y. J.; Wang, J.; Zhang, C. L.; Chang, C. J.; Yan, J.; Qiu, L.; Wu, M. M.; Guo, Z. J. A platinum anticancer theranostic agent with magnetic targeting potential derived from maghemite nanoparticles Chem. Sci. 2013, 4, 2605-2612 10.1039/c3sc50554e
42. Wang, J. Z.; Wang, X. Y.; Song, Y. J.; Zhu, C. C.; Wang, J.; Wang, K.; Guo, Z. J. Detecting and delivering platinum anticancer drugs using fluorescent maghemite nanoparticles Chem. Commun. 2013, 49, 2786-2788 10.1039/c3cc39059d
43. Vivero-Escoto, J. L.; Huxford-Phillips, R. C.; Lin, W. Silica-based nanoprobes for biomedical imaging and theranostic applications Chem. Soc. Rev. 2012, 41, 2673-2685 10.1039/c2cs15229k
44. Peng, F.; Su, Y. Y.; Zhong, Y. L.; Fan, C. H.; Lee, S.-T.; He, Y. Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy Acc. Chem. Res. 2014, 47, 612-623 10.1021/ar400221g
45. Zhu, X. M.; Wang, Y. X. J.; Leung, K. C. F.; Lee, S. F.; Zhao, F.; Wang, D. W.; Lai, J. M. Y.; Wan, C.; Cheng, C. H. K.; Ahuja, A. T. Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines Int. J. Nanomed. 2012, 7, 953-964 10.2147/IJN.S28316
46. Sun, L.-D.; Wang, Y.-F.; Yan, C.-H. Paradigms and challenges for bioapplication of rare earth upconversion luminescent nanoparticles: Small size and tunable emission/excitation spectra Acc. Chem. Res. 2014, 47, 1001-1009 10.1021/ar400218t
47. Dai, Y. L.; Xiao, H. H.; Liu, J. H.; Yuan, Q. H.; Ma, P. A.; Yang, D. M.; Li, C. X.; Cheng, Z. Y.; Hou, Z. Y.; Yang, P. P.; Lin, J. In vivo multimodality imaging and cancer therapy by near-infrared light-triggered trans-platinum pro-drug-conjugated upconverison nanoparticles J. Am. Chem. Soc. 2013, 135, 18920-18929 10.1021/ja410028q
48. Min, Y. Z.; Li, J. M.; Liu, F.; Yeow, E. K. L.; Xing, B. G. Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles Angew. Chem., Int. Ed. 2014, 53, 1012-1016 10.1002/anie.201308834
49. Zhu, Z. Z.; Wang, X. Y.; Li, T. J.; Aime, S.; Sadler, P. J.; Guo, Z. J. Platinum(II)-gadolinium(III) complexes as potential single-molecular theranostic agents for cancer treatment Angew. Chem., Int. Ed. 2014, 53, 13225-13228 10.1002/anie.201407406
50. Maldonado, C. R.; Salassa, L.; Gomez-Blanco, N.; Mareque-Rivas, J. C. Nano-functionalization of metal complexes for molecular imaging and anticancer therapy Coord. Chem. Rev. 2013, 257, 2668-2688 10.1016/j.ccr.2013.04.014
51. Kaida, S.; Cabral, H.; Kumagai, M.; Kishimura, A.; Terada, Y.; Sekino, M.; Aoki, I.; Nishiyama, N.; Tani, T.; Kataoka, K. Visible drug delivery by supramolecular nanocarriers directing to single-platformed diagnosis and therapy of pancreatic tumor model Cancer Res. 2010, 70, 7031-7041 10.1158/0008-5472.CAN-10-0303
52. Mi, P.; Cabral, H.; Kokuryo, D.; Rafi, M.; Terada, Y.; Aoki, I.; Saga, T.; Takehiko, I.; Nishiyama, N.; Kataoka, K. Gd-DTPA-loaded polymeremetal complex micelles with high relaxivity for MR cancer imaging Biomaterials 2013, 34, 492-500 10.1016/j.biomaterials.2012.09.030
53. Dong, X. D.; Wang, X. Y.; Lin, M. X.; Sun, H.; Yang, X. L.; Guo, Z. J. Promotive effect of the platinum moiety on the DNA cleavage activity of copper-based artificial nucleases Inorg. Chem. 2010, 49, 2541-2549 10.1021/ic100001x
54. Johnstone, T. C.; Alexander, S. M.; Lin, W.; Lippard, S. J. Effects of monofunctional platinum agents on bacterial growth: A retrospective study J. Am. Chem. Soc. 2014, 136, 116-118 10.1021/ja411742c
55. Zhang, L. Y.; Zheng, Y. C.; Callahan, B.; Belfort, M.; Liu, Y. Z. Cisplatin inhibits protein splicing, suggesting inteins as therapeutic targets in mycobacteria J. Biol. Chem. 2011, 286, 1277-1282 10.1074/jbc.M110.171124
56. Valensin, D.; Gabbiani, C.; Messori, L. Metal compounds as inhibitors of β-amyloid aggregation. Perspectives for an innovative metallotherapeutics on Alzheimer's disease Coord. Chem. Rev. 2012, 256, 2357-2366 10.1016/j.ccr.2012.04.010
57. Wang, X. H.; Wang, X. Y.; Zhang, C. L.; Jiao, Y.; Guo, Z. J. Inhibitory action of macrocyclic platiniferous chelators on metal-induced Aβ aggregation Chem. Sci. 2012, 3, 1304-1312 10.1039/c2sc01100j
58. Celli, J. P.; Spring, B. Q.; Rizvi, I.; Evans, C. L.; Samkoe, K. S.; Verma, S.; Pogue, B. W.; Hasan, T. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization Chem. Rev. 2010, 110, 2795-2838 10.1021/cr900300p
59. Zhang, W.; Li, Y.; Sun, J.-H.; Tan, C.-P.; Ji, L.-N.; Mao, Z.-W. Supramolecular self-assembled nanoparticles for chemo-photodynamic dual therapy against cisplatin resistant cancer cells Chem. Commun. 2015, 51, 1807-1810 10.1039/C4CC08583C
60. Lau, J. T. F.; Lo, P.-C.; Fong, W.-P.; Ng, D. K. P. A zinc(II) phthalocyanine conjugated with an oxaliplatin derivative for dual chemo- and photodynamic therapy J. Med. Chem. 2012, 55, 5446-5454 10.1021/jm300398q
61. Naik, A.; Rubbiani, R.; Gasser, G.; Spingler, B. Visible-light-induced annihilation of tumor cells with platinum-porphyrin conjugates Angew. Chem., Int. Ed. 2014, 53, 6938-6941 10.1002/anie.201400533
62. Wong, D. Y. Q.; Yeo, C. H. F.; Ang, W. H. Immuno-chemotherapeutic platinum(IV) prodrugs of cisplatin as multimodal anticancer agents Angew. Chem., Int. Ed. 2014, 53, 6752-6756 10.1002/anie.201402879
63. Song, Y.; Suntharalingam, K.; Yeung, J. S.; Royzen, M.; Lippard, S. J. Synthesis and characterization of Pt(IV) fluorescein conjugates to investigate Pt(IV) intracellular transformations Bioconjugate Chem. 2013, 24, 1733-1740 10.1021/bc400281a
64. Guo, Z. Q.; Tong, W.-L.; Chan, M. C. W. Luminescent oligo(ethylene glycol)-functionalized cyclometalated platinum(II) complexes: Cellular characterization and mitochondria-specific localization Chem. Commun. 2014, 50, 1711-1714 10.1039/c3cc47150k
65. Koo, C.-K.; So, L. K. -Y.; Wong, K.-L.; Ho, Y.-M.; Lam, Y.-W.; Lam, M. H. -W.; Cheah, K.-W.; Cheng, C. C. -W.; Kwok, W.-M. A triphenylphosphonium-functionalised cyclometalated platinum(II) complex as a nucleolus-specific two-photon molecular dye Chem.-Eur. J. 2010, 16, 3942-3950 10.1002/chem.200902919
66. Wu, S. D.; Wang, X. Y.; Zhu, C. C.; Song, Y. J.; Wang, J.; Li, Y. Z.; Guo, Z. J. Monofunctional platinum complexes containing a 4-nitrobenzo-2-oxa-1,3-diazole fluorophore: Distribution in tumour cells Dalton Trans. 2011, 40, 10376-10382 10.1039/c1dt10555h
67. Mauro, M.; Aliprandi, A.; Septiadi, D.; Kehr, N. S.; De Cola, L. When self-assembly meets biology: luminescent platinum complexes for imaging applications Chem. Soc. Rev. 2014, 43, 4144-4166 10.1039/c3cs60453e
68. Ma, D.-L.; He, H.-Z.; Leung, K.-H.; Chan, D. S. -H.; Leung, C.-H. Bioactive luminescent transition-metal complexes for biomedical applications Angew. Chem., Int. Ed. 2013, 52, 7666-7682 10.1002/anie.201208414